UNASSIGNED: We report the case of a 50-year-old female Jehovah's Witness with advanced @entity418 who underwent esophagectomy following induction chemotherapy. She visited our hospital complaining of @entity1282 and was diagnosed of advanced @entity418 by upper endoscopy. She refused allogeneic transfusion. Induction chemotherapy was performed. Severe @entity417 occurred as an adverse event. A subtotal esophagectomy was performed after her @entity417 improved. During the surgery, a large volume of replacement fluid was injected, the blood was diluted, and @entity954 was relatively reduced. Intraoperative blood salvage was made using Cell Saver. The postoperative course were stable by using autologous blood and albumin infusion. The @entity1 was discharged on postoperative day 27. Jehovah's Witnesses with @entity344 can be treated safely by performing surgical therapy based on blood replacement therapy and autologous blood transfusion. J. Med. Invest. 62: 264-267, August, 2015.

A case of thoracic XXXX undergone esophagectomy after induction chemotherapy in a Jehovah's Witness.

@entity1 :: ('9606', 'Species') :: ['patient'] @entity417 :: ('MESH:D000740', 'Disease') :: ['anemia'] @entity344 :: ('MESH:D005767', 'Disease') :: ['gastrointestinal malignancies'] @entity418 :: ('MESH:D004938', 'Disease') :: ['esophageal cancer'] @entity1282 :: ('MESH:D003680', 'Disease') :: ['dysphagia'] @entity954 :: ('MESH:D016063', 'Disease') :: ['intraoperative bleeding']
@entity418 :: (MESH:D004938,Disease) :: ['esophageal cancer']
